Yunfan Bai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yunfan Bai has a total of 105 co-authors. Here are the top co-authors by number of shared publications:
- Aurelien Dugourd
EMBL-EBI, Wellcome Genome Campus, UK
5 shared publications - Julio Saez-Rodriguez
Faculty of Medicine, Heidelberg University, Heidelberg, Germany
5 shared publications - Diego Mañanes
Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
4 shared publications - Dénes Türei
Heidelberg University
4 shared publications - Balazs Bohar
Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom
3 shared publications - Christina Schmidt
Faculty of Medicine and Heidelberg University Hospital, Institute for Computational Biomedicine, Heidelberg University, Heidelberg, Germany
3 shared publications
Latest Publications
- Open Access
Combining prior knowledge and transcriptomics data for logic models of patient subgroups
Computational modeling provides a powerful framework for in silico exploration of anti-cancer therapeutic targets and tumor response mechanisms. Oncogenic signaling pathways play a central role in tumor behavior and represent promising targets for personalized combination therapies. However, these pathways are complex, and although logic-based models are well suited for representing signaling dynamics, they are often constrained by model-specific data requirements, limited scalability, and time-consuming manual curation. Here, we introduce Functional Integration of Contextualized Omics for Unraveling regulatory dynamicS (FICUS), a framework that integrates omics-driven network contextualization with dynamic Boolean and logic-ODE modeling. FICUS enables automated, data-driven protein network inference and patient stratification, allowing shared signaling mechanisms to be identified across patient subgroups while preserving patient-specific dynamic responses. We applied FICUS to the SU2C-MARK lung cancer cohort and the The Cancer Genome Atlas kidney cancer cohort, demonstrating its utility for post-hoc analyses and downstream interrogation of dynamic tumor models. Overall, our results highlight the flexibility of FICUS in capturing heterogeneous signaling mechanisms across patient subgroups, addressing a key challenge in precision oncology.
Open AccessCombining prior knowledge and transcriptomics data for logic models of patient subgroups
Computational modeling provides a powerful framework for in silico exploration of anti-cancer therapeutic targets and tumor response mechanisms. Oncogenic signaling pathways play a central role in tumor behavior and represent promising targets for personalized combination therapies. However, these pathways are complex, and although logic-based models are well suited for representing signaling dynamics, they are often constrained by model-specific data requirements, limited scalability, and time-consuming manual curation. Here, we introduce Functional Integration of Contextualized Omics for Unraveling regulatory dynamicS (FICUS), a framework that integrates omics-driven network contextualization with dynamic Boolean and logic-ODE modeling. FICUS enables automated, data-driven protein network inference and patient stratification, allowing shared signaling mechanisms to be identified across patient subgroups while preserving patient-specific dynamic responses. We applied FICUS to the SU2C-MARK lung cancer cohort and the The Cancer Genome Atlas kidney cancer cohort, demonstrating its utility for post-hoc analyses and downstream interrogation of dynamic tumor models. Overall, our results highlight the flexibility of FICUS in capturing heterogeneous signaling mechanisms across patient subgroups, addressing a key challenge in precision oncology.
- Open Access
OmniPath Metabo: chemical structures, interactions and mechanisms to study the metabolome
Mechanistic and functional analysis of omics data largely relies on the incorporation of prior knowledge; however, connecting metabolomics data and knowledge is a major methodological challenge. This is largely driven by the diverse prior knowledge being fragmented across many databases requiring the merging of different database records across chemical structures, identifiers, and varying levels of structural specificity. Hence, this limits mechanistic interpretation and functional characterisation of the metabolome. Here, we present OmniPath Metabo, a comprehensive, harmonized, metabolome-centric database covering metabolites, lipids, food-derived compounds, and small molecule drugs, along with their associated receptors, transporters, enzymes, reactions, allosteric regulators, and disease associations. OmniPath Metabo harmonizes attributes using controlled vocabularies and ontologies, structures and built-in cheminformatics to map identifiers and track ambiguity. OmniPath Metabo is built directly from 40+ original resources and is freely accessible via an interactive web app and API at metabo.omnipathdb.org . OmniPath Metabo enables dynamic, context-specific construction of subnetworks to serve dedicated purposes, such as cell-cell communication or integrated multi-omics metabolite-driven regulation, connecting reactions, allosteric regulation, metabolite-receptor and metabolite-transporter interactions. Combining it with the over 170 other resources in OmniPath, it can be used for integrated networks of signaling, gene regulation, and metabolism. We showcase the application of OmniPath Metabo by analysing publicly available metabolomics data of lung cancer cell lines and metabolic footprints to mutational patterns. In summary, OmniPath Metabo transforms fragmented resources into a harmonised prior knowledge framework for a mechanistic and functional analysis of the metabolome.
Open AccessOmniPath Metabo: chemical structures, interactions and mechanisms to study the metabolome
Mechanistic and functional analysis of omics data largely relies on the incorporation of prior knowledge; however, connecting metabolomics data and knowledge is a major methodological challenge. This is largely driven by the diverse prior knowledge being fragmented across many databases requiring the merging of different database records across chemical structures, identifiers, and varying levels of structural specificity. Hence, this limits mechanistic interpretation and functional characterisation of the metabolome. Here, we present OmniPath Metabo, a comprehensive, harmonized, metabolome-centric database covering metabolites, lipids, food-derived compounds, and small molecule drugs, along with their associated receptors, transporters, enzymes, reactions, allosteric regulators, and disease associations. OmniPath Metabo harmonizes attributes using controlled vocabularies and ontologies, structures and built-in cheminformatics to map identifiers and track ambiguity. OmniPath Metabo is built directly from 40+ original resources and is freely accessible via an interactive web app and API at metabo.omnipathdb.org . OmniPath Metabo enables dynamic, context-specific construction of subnetworks to serve dedicated purposes, such as cell-cell communication or integrated multi-omics metabolite-driven regulation, connecting reactions, allosteric regulation, metabolite-receptor and metabolite-transporter interactions. Combining it with the over 170 other resources in OmniPath, it can be used for integrated networks of signaling, gene regulation, and metabolism. We showcase the application of OmniPath Metabo by analysing publicly available metabolomics data of lung cancer cell lines and metabolic footprints to mutational patterns. In summary, OmniPath Metabo transforms fragmented resources into a harmonised prior knowledge framework for a mechanistic and functional analysis of the metabolome.
- Open Access
- 18 November 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (D1) , D652-D660
OmniPath: integrated knowledgebase for multi-omics analysis
Analysis and interpretation of omics data largely benefit from the use of prior knowledge. However, this knowledge is fragmented across resources and often is not directly accessible for analytical methods. We developed OmniPath (https://omnipathdb.org/), a database combining diverse molecular knowledge from 168 resources. It covers causal protein–protein, gene regulatory, microRNA, and enzyme–post-translational modification interactions, cell–cell communication, protein complexes, and information about the function, localization, structure, and many other aspects of biomolecules. It prioritizes literature curated data, and complements it with predictions and large scale databases. To enable interactive browsing of this large corpus of knowledge, we developed OmniPath Explorer, which also includes a large language model agent that has direct access to the database. Python and R/Bioconductor client packages and a Cytoscape plugin create easy access to customized prior knowledge for omics analysis environments, such as scverse. OmniPath can be broadly used for the analysis of bulk, single-cell, and spatial multi-omics data, especially for mechanistic and causal modeling.
- 18 November 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (D1) , D652-D660
Open AccessOmniPath: integrated knowledgebase for multi-omics analysis
Analysis and interpretation of omics data largely benefit from the use of prior knowledge. However, this knowledge is fragmented across resources and often is not directly accessible for analytical methods. We developed OmniPath (https://omnipathdb.org/), a database combining diverse molecular knowledge from 168 resources. It covers causal protein–protein, gene regulatory, microRNA, and enzyme–post-translational modification interactions, cell–cell communication, protein complexes, and information about the function, localization, structure, and many other aspects of biomolecules. It prioritizes literature curated data, and complements it with predictions and large scale databases. To enable interactive browsing of this large corpus of knowledge, we developed OmniPath Explorer, which also includes a large language model agent that has direct access to the database. Python and R/Bioconductor client packages and a Cytoscape plugin create easy access to customized prior knowledge for omics analysis environments, such as scverse. OmniPath can be broadly used for the analysis of bulk, single-cell, and spatial multi-omics data, especially for mechanistic and causal modeling.
- Open Access
OmniPath: integrated knowledgebase for multi-omics analysis
Analysis and interpretation of omics data largely benefit from the use of prior knowledge. However, this knowledge is fragmented across resources and often is not directly accessible for analytical methods. We developed OmniPath ( https://omnipathdb.org/ ), a database combining diverse molecular knowledge from 168 resources. It covers causal protein-protein, gene regulatory, miRNA, and enzyme-PTM (post-translational modification) interactions, cell-cell communication, protein complexes, and information about the function, localization, structure, and many other aspects of biomolecules. It prioritizes literature curated data, and complements it with predictions and large scale databases. To enable interactive browsing of this large corpus of knowledge, we developed OmniPath Explorer, which also includes a large language model (LLM) agent that has direct access to the database. Python and R/Bioconductor client packages and a Cytoscape plugin create easy access to customized prior knowledge for omics analysis environments, such as scverse. OmniPath can be broadly used for the analysis of bulk, single-cell and spatial multi-omics data, especially for mechanistic and causal modeling. Graphical
Open AccessOmniPath: integrated knowledgebase for multi-omics analysis
Analysis and interpretation of omics data largely benefit from the use of prior knowledge. However, this knowledge is fragmented across resources and often is not directly accessible for analytical methods. We developed OmniPath ( https://omnipathdb.org/ ), a database combining diverse molecular knowledge from 168 resources. It covers causal protein-protein, gene regulatory, miRNA, and enzyme-PTM (post-translational modification) interactions, cell-cell communication, protein complexes, and information about the function, localization, structure, and many other aspects of biomolecules. It prioritizes literature curated data, and complements it with predictions and large scale databases. To enable interactive browsing of this large corpus of knowledge, we developed OmniPath Explorer, which also includes a large language model (LLM) agent that has direct access to the database. Python and R/Bioconductor client packages and a Cytoscape plugin create easy access to customized prior knowledge for omics analysis environments, such as scverse. OmniPath can be broadly used for the analysis of bulk, single-cell and spatial multi-omics data, especially for mechanistic and causal modeling. Graphical
- Open Access
Modeling causal signal propagation in multi-omic factor space with COSMOS
Understanding complex diseases requires approaches that jointly analyze omics data across multiple biological layers, including signaling, gene regulation, and metabolism. Existing data-driven multi-omics analysis methods, such as multi-omics factor analysis (MOFA), can identify associations between molecular features and phenotypes, but they are not designed to integrate existing mechanistic molecular knowledge, which can provide further actionable insights. We introduce an approach that connects data-driven analysis of multi-omics data with systematic integration of mechanistic prior knowledge using COSMOS+ (Causal Oriented Search of Multi-Omics Space). We show how factor analysis output can be used to estimate activities of transcription factors and kinases as well as ligand-receptor interactions, which in turn are integrated with network-level prior-knowledge to generate mechanistic hypotheses about paths connecting deregulated molecular features. We apply this approach on a novel multi-omics dataset of cell line models of breast cancer resistance to evaluate the ability of such mechanistic hypotheses to identify resistance drivers, as well as a breast cancer patient cohort. Our approach offers an interpretable framework to generate actionable insights from multi-omic data particularly suited for high dimensional datasets.
Open AccessModeling causal signal propagation in multi-omic factor space with COSMOS
Understanding complex diseases requires approaches that jointly analyze omics data across multiple biological layers, including signaling, gene regulation, and metabolism. Existing data-driven multi-omics analysis methods, such as multi-omics factor analysis (MOFA), can identify associations between molecular features and phenotypes, but they are not designed to integrate existing mechanistic molecular knowledge, which can provide further actionable insights. We introduce an approach that connects data-driven analysis of multi-omics data with systematic integration of mechanistic prior knowledge using COSMOS+ (Causal Oriented Search of Multi-Omics Space). We show how factor analysis output can be used to estimate activities of transcription factors and kinases as well as ligand-receptor interactions, which in turn are integrated with network-level prior-knowledge to generate mechanistic hypotheses about paths connecting deregulated molecular features. We apply this approach on a novel multi-omics dataset of cell line models of breast cancer resistance to evaluate the ability of such mechanistic hypotheses to identify resistance drivers, as well as a breast cancer patient cohort. Our approach offers an interpretable framework to generate actionable insights from multi-omic data particularly suited for high dimensional datasets.
- 4 March 2024
- Published by Springer Nature in Environmental Science and Pollution Research
- Vol. 31 (16) , 24113-24128
In-situ synthesis of ZIF-8 on magnetic pineapple leaf biochar as an efficient and reusable adsorbent for methylene blue removal from wastewater
The presence of organic dyes in aquatic systems poses a significant threat to ecosystems and human well-being. Due to recycling challenges, traditional commercial activated carbon is not cost-effective. To address this, an imidazolate acid zeolite framework-8 (ZIF-8)-modified magnetic adsorbent (ZMPLB-800) was synthesized through the in-situ formation of ZIF-8 and subsequent carbonization at 800 °C, using magnetic pineapple leaf biochar (MPLB) as a carrier. The porous structure of ZMPLB-800 facilitates the rapid passage of dye molecules, enhancing adsorption performance. ZMPLB-800 exhibited remarkable adsorption capacity for methylene blue (MB) across a pH range of 3–13, with a maximum adsorption capacity of 455.98 mg g−1. Adsorption kinetics and thermodynamics followed the pseudo-second-order kinetic model and Langmuir isotherm model. Mechanisms of MB adsorption included pore filling, hydrogen bonding, electrostatic interactions, π-π interactions, and complexation through surface functional groups. Additionally, ZMPLB-800 demonstrated excellent regeneration performance, recording a removal efficiency exceeding 87% even after five adsorption/desorption cycles. This study provides a novel strategy for treating dye wastewater with MOF composites, laying the foundation for waste biomass utilization. Graphical Abstract
- 4 March 2024
- Published by Springer Nature in Environmental Science and Pollution Research
- Vol. 31 (16) , 24113-24128
In-situ synthesis of ZIF-8 on magnetic pineapple leaf biochar as an efficient and reusable adsorbent for methylene blue removal from wastewater
The presence of organic dyes in aquatic systems poses a significant threat to ecosystems and human well-being. Due to recycling challenges, traditional commercial activated carbon is not cost-effective. To address this, an imidazolate acid zeolite framework-8 (ZIF-8)-modified magnetic adsorbent (ZMPLB-800) was synthesized through the in-situ formation of ZIF-8 and subsequent carbonization at 800 °C, using magnetic pineapple leaf biochar (MPLB) as a carrier. The porous structure of ZMPLB-800 facilitates the rapid passage of dye molecules, enhancing adsorption performance. ZMPLB-800 exhibited remarkable adsorption capacity for methylene blue (MB) across a pH range of 3–13, with a maximum adsorption capacity of 455.98 mg g−1. Adsorption kinetics and thermodynamics followed the pseudo-second-order kinetic model and Langmuir isotherm model. Mechanisms of MB adsorption included pore filling, hydrogen bonding, electrostatic interactions, π-π interactions, and complexation through surface functional groups. Additionally, ZMPLB-800 demonstrated excellent regeneration performance, recording a removal efficiency exceeding 87% even after five adsorption/desorption cycles. This study provides a novel strategy for treating dye wastewater with MOF composites, laying the foundation for waste biomass utilization. Graphical Abstract
- Open Access
Trans-omic analysis reveals opposite metabolic dysregulation between feeding and fasting in liver associated with obesity
SUMMARY: Dysregulation of liver metabolism associated with obesity during feeding and fasting leads to the breakdown of metabolic homeostasis. However, the underlying mechanism remains unknown. Here, we measured multi-omics data in the liver of wild-type and leptin-deficient obese ( ob / ob ) mice at ad libitum feeding, and constructed a differential regulatory trans-omic network of metabolic reactions. We compared the trans-omic network at feeding with that at 16 h-fasting constructed in our previous study. Intermediate metabolites in glycolytic and nucleotide metabolism decreased in ob / ob mice at feeding but increased at fasting. Allosteric regulation reversely shifted between feeding and fasting, generally showing activation at feeding while inhibition at fasting in ob / ob mice. Transcriptional regulation was similar between feeding and fasting, generally showing inhibiting transcription factor regulations, activating enzyme protein regulations in ob / ob mice. The opposite metabolic dysregulation between feeding and fasting characterizes breakdown of metabolic homeostasis associated with obesity.
Open AccessTrans-omic analysis reveals opposite metabolic dysregulation between feeding and fasting in liver associated with obesity
SUMMARY: Dysregulation of liver metabolism associated with obesity during feeding and fasting leads to the breakdown of metabolic homeostasis. However, the underlying mechanism remains unknown. Here, we measured multi-omics data in the liver of wild-type and leptin-deficient obese ( ob / ob ) mice at ad libitum feeding, and constructed a differential regulatory trans-omic network of metabolic reactions. We compared the trans-omic network at feeding with that at 16 h-fasting constructed in our previous study. Intermediate metabolites in glycolytic and nucleotide metabolism decreased in ob / ob mice at feeding but increased at fasting. Allosteric regulation reversely shifted between feeding and fasting, generally showing activation at feeding while inhibition at fasting in ob / ob mice. Transcriptional regulation was similar between feeding and fasting, generally showing inhibiting transcription factor regulations, activating enzyme protein regulations in ob / ob mice. The opposite metabolic dysregulation between feeding and fasting characterizes breakdown of metabolic homeostasis associated with obesity.
- 4 June 2019
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 11 (29) , 3678-3686
Optimization of the sample preparation method for adherent cell metabolomics based on ultra-performance liquid chromatography coupled to mass spectrometry
Sample preparation plays a crucial role in generating data with satisfactory quality and stability for metabolomics studies, especially those conducted on cells cultured in vitro. Thus, to carry out a preparation procedure with a low risk of systematic error, the operating steps for a cell metabolomics study were optimized step by step, which include cell quenching, harvesting, cracking, leveling and extraction. First, the metabolites presenting high amounts, including amino acids, acylcarnitines and phosphatidylcholines, were screened out from the other metabolites. Consequently, six acylcarnitines revealed much better concentration–response linearity (R2 > 0.95) than others. Thus, the candidate methods for each step were evaluated via the comparison of the relative standard deviations of the screened metabolites among cell duplicates. Liquid nitrogen for quenching, trypsinization for harvesting, sonication for cracking, cell counting for leveling, and the sole use of methanol for metabolite extraction were the methods presenting the best repeatability compared with the corresponding counterpart methods. Additionally, samples cracked with sonication as well as those quenched with liquid nitrogen revealed significantly higher intensities than the corresponding counterpart methods. To further explore the metabolic disturbances caused by trypsinization, the metabolic profile of trypsinization-treated cells was compared with that of those harvested by scraping using multivariate analysis and metabolic enrichment analysis. Glycine, serine and threonine metabolism as well as glycerophospholipid metabolism showed the most significant variations due to the biochemically associated metabolites mapped in them. In conclusion, this study would prospectively provide analysts and biologists with a helpful reference for choosing methods for sample preparation in cell metabolomics studies.
- 4 June 2019
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 11 (29) , 3678-3686
Optimization of the sample preparation method for adherent cell metabolomics based on ultra-performance liquid chromatography coupled to mass spectrometry
Sample preparation plays a crucial role in generating data with satisfactory quality and stability for metabolomics studies, especially those conducted on cells cultured in vitro. Thus, to carry out a preparation procedure with a low risk of systematic error, the operating steps for a cell metabolomics study were optimized step by step, which include cell quenching, harvesting, cracking, leveling and extraction. First, the metabolites presenting high amounts, including amino acids, acylcarnitines and phosphatidylcholines, were screened out from the other metabolites. Consequently, six acylcarnitines revealed much better concentration–response linearity (R2 > 0.95) than others. Thus, the candidate methods for each step were evaluated via the comparison of the relative standard deviations of the screened metabolites among cell duplicates. Liquid nitrogen for quenching, trypsinization for harvesting, sonication for cracking, cell counting for leveling, and the sole use of methanol for metabolite extraction were the methods presenting the best repeatability compared with the corresponding counterpart methods. Additionally, samples cracked with sonication as well as those quenched with liquid nitrogen revealed significantly higher intensities than the corresponding counterpart methods. To further explore the metabolic disturbances caused by trypsinization, the metabolic profile of trypsinization-treated cells was compared with that of those harvested by scraping using multivariate analysis and metabolic enrichment analysis. Glycine, serine and threonine metabolism as well as glycerophospholipid metabolism showed the most significant variations due to the biochemically associated metabolites mapped in them. In conclusion, this study would prospectively provide analysts and biologists with a helpful reference for choosing methods for sample preparation in cell metabolomics studies.
- Open Access
- 16 January 2019
- Published by Wiley in International Journal of Cancer
- Vol. 144 (8) , 2033-2042
Selection of small plasma peptides for the auxiliary diagnosis and prognosis of epithelial ovarian cancer by using UPLC/MS‐based nontargeted and targeted analyses
Epithelial ovarian cancer (EOC) is the leading cause of gynecologic cancer‐related death due to its non‐specific characteristics compared to benign cases and poor prognosis after conventional therapies. Small peptides (SPs) demonstrated to have potential for diagnosis and prognosis were focused on in this study for the discovery of biomarkers that address these issues. Metabolic profiles of fifteen SPs, including nine dipeptides and six tripeptides were acquired from plasma samples of 140 EOC and 158 benign ovarian tumor (BOT) patients. Partial least square discriminant analysis showed separations between EOC and BOT subjects of different age brackets. Hyp‐Leu, Glu‐Trp and Phe‐Phe were selected as promising predictive SP‐biomarkers for better EOC diagnosis compared to conventional biomarkers. Combined Hyp‐Leu, Glu‐Trp and CA125 presented an area under the curve (AUC) of 0.904, with a sensitivity and specificity of 0.804 and 0.944, respectively. This finding suggested that the combination of these biomarkers performed much better than CA125 alone. Hyp‐Leu and Gly‐Phe‐Trp showed significantly improved performances in the log‐rank tests and Kaplan‐Meier curves demonstrating their prognostic potential. All SP‐biomarkers proved to have excellent stabilities at room temperature. Correlation network analysis implied latent conversions among amino acids, dipeptides and tripeptides during EOC. In conclusion, the selected SPs in combination with CA125 show profound promise for discriminating EOCs from BOTs and for predicting the progression after surgery, which provides invaluable information for clinicians in the precision diagnosis and treatment of EOC.
- 16 January 2019
- Published by Wiley in International Journal of Cancer
- Vol. 144 (8) , 2033-2042
Open AccessSelection of small plasma peptides for the auxiliary diagnosis and prognosis of epithelial ovarian cancer by using UPLC/MS‐based nontargeted and targeted analyses
Epithelial ovarian cancer (EOC) is the leading cause of gynecologic cancer‐related death due to its non‐specific characteristics compared to benign cases and poor prognosis after conventional therapies. Small peptides (SPs) demonstrated to have potential for diagnosis and prognosis were focused on in this study for the discovery of biomarkers that address these issues. Metabolic profiles of fifteen SPs, including nine dipeptides and six tripeptides were acquired from plasma samples of 140 EOC and 158 benign ovarian tumor (BOT) patients. Partial least square discriminant analysis showed separations between EOC and BOT subjects of different age brackets. Hyp‐Leu, Glu‐Trp and Phe‐Phe were selected as promising predictive SP‐biomarkers for better EOC diagnosis compared to conventional biomarkers. Combined Hyp‐Leu, Glu‐Trp and CA125 presented an area under the curve (AUC) of 0.904, with a sensitivity and specificity of 0.804 and 0.944, respectively. This finding suggested that the combination of these biomarkers performed much better than CA125 alone. Hyp‐Leu and Gly‐Phe‐Trp showed significantly improved performances in the log‐rank tests and Kaplan‐Meier curves demonstrating their prognostic potential. All SP‐biomarkers proved to have excellent stabilities at room temperature. Correlation network analysis implied latent conversions among amino acids, dipeptides and tripeptides during EOC. In conclusion, the selected SPs in combination with CA125 show profound promise for discriminating EOCs from BOTs and for predicting the progression after surgery, which provides invaluable information for clinicians in the precision diagnosis and treatment of EOC.